Profile data is unavailable for this security.
About the company
CTS Corporation is a manufacturer of sensors, connectivity components, and actuators. The Company designs, manufactures, and sells a line of sensors, connectivity components, and actuators primarily to original equipment manufacturers (OEMs) and supplies for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Its products perform specific electronic functions for a given product family and are intended for use in customer assemblies. The Company’s products consist principally of sensors and actuators used in passenger or commercial vehicles, connectivity components used in telecommunications infrastructure, information technology and other high-speed applications, switches, temperature sensors, and potentiometers supplied to multiple markets, and fabricated piezoelectric materials and substrates used primarily in medical, industrial, aerospace and defense, and information technology markets.
- Revenue in USD (TTM)503.41m
- Net income in USD-36.08m
- Incorporated1929
- Employees3.79k
- LocationCTS Corp4925 Indiana AveLISLE 60532-1611United StatesUSA
- Phone+1 (630) 577-8800
- Fax+1 (574) 294-5178
- Websitehttps://www.ctscorp.com/
Mergers & acquisitions
| Acquired company | CTS:NYQ since announced | Transaction value |
|---|---|---|
| Sensor Scientific Inc | 1.90% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diebold Nixdorf Inc | 3.99bn | -191.00m | 791.37m | 22.00k | -- | -- | -- | 0.1984 | -2.45 | -2.45 | 51.15 | -10.87 | 1.10 | 5.22 | 6.50 | 181,295.50 | -5.20 | -6.65 | -9.18 | -11.74 | 28.01 | 23.25 | -4.73 | -6.88 | 0.7722 | 0.5563 | 1.56 | -- | -11.49 | 10.03 | 21.15 | -- | -12.06 | -- |
| 908 Devices Inc. | 25.59m | -25.50m | 884.77m | 101.00 | -- | 6.96 | -- | 34.58 | -1.34 | -1.34 | 1.03 | 4.60 | 0.2479 | 1.92 | 2.45 | 253,316.80 | -24.68 | -- | -27.28 | -- | 53.55 | -- | -99.54 | -- | 13.35 | -20.40 | 0.1059 | -- | 49.64 | -- | 4.25 | -- | -- | -- |
| CTS Corporation | 503.41m | -36.08m | 1.11bn | 3.79k | -- | 2.43 | -- | 2.21 | -1.12 | -1.12 | 15.47 | 14.10 | 0.7698 | 7.03 | 6.51 | 132,966.50 | -5.52 | 6.56 | -6.52 | 7.98 | 35.49 | 34.01 | -7.17 | 8.42 | 2.16 | 56.49 | 0.0986 | 14.24 | -9.58 | 2.09 | -4.04 | 37.91 | 8.85 | 0.00 |
| FARO Technologies, Inc. | 322.13m | 19.99m | 1.27bn | 1.36k | 65.09 | 3.56 | 38.15 | 3.94 | 1.07 | 1.07 | 17.78 | 19.66 | 0.6733 | 2.85 | 5.96 | 236,165.70 | 4.18 | -10.30 | 5.24 | -12.63 | 53.69 | -- | 6.20 | -17.06 | 2.36 | -- | 0.0008 | -- | -20.43 | -0.8834 | 101.01 | -45.27 | -17.93 | -- |
| Cue Health Inc | 219.92m | 4.77m | 1.29bn | 1.25k | 269.98 | -- | 87.53 | 5.85 | 0.0332 | 0.0332 | 1.53 | 0.7999 | -- | -- | -- | 175,370.80 | -- | -- | -- | -- | 54.47 | -- | 2.17 | -- | 2.08 | 1.68 | 0.696 | -- | 246.41 | -- | -129.80 | -- | -- | -- |
| IMPINJ Inc | 174.16m | -46.96m | 1.36bn | 310.00 | -- | -- | -- | 7.80 | -1.98 | -1.98 | 7.31 | -- | 0.8486 | 3.08 | 7.78 | 561,796.80 | -22.88 | -15.94 | -33.11 | -18.46 | 50.06 | 49.36 | -26.97 | -19.81 | 1.35 | -14.38 | 0.4852 | -- | -9.10 | 12.10 | -125.88 | -- | -16.23 | -- |
| BioNano Genomics Inc | 13.21m | -51.26m | 1.41bn | 147.00 | -- | 4.07 | -- | 106.71 | -0.2609 | -0.2609 | 0.0634 | 1.24 | 0.0688 | 2.15 | 4.34 | 89,863.81 | -26.69 | -- | -28.98 | -- | 33.28 | -- | -388.00 | -- | 31.41 | -24.42 | 0.00 | -- | -16.06 | -- | -37.87 | -- | -- | -- |
| Berkeley Lights Inc | 77.83m | -54.46m | 1.55bn | 230.00 | -- | 6.69 | -- | 19.94 | -0.8322 | -0.8322 | 1.19 | 3.46 | 0.375 | 2.05 | 4.35 | 338,408.70 | -26.17 | -- | -29.76 | -- | 67.83 | -- | -69.79 | -- | 8.84 | -45.55 | 0.0782 | -- | 13.42 | -- | -101.48 | -- | -- | -- |
| Mesa Laboratories, Inc. | 138.92m | 4.05m | 1.59bn | 506.00 | 445.30 | 3.98 | 70.97 | 11.43 | 0.6854 | 0.6854 | 25.97 | 76.75 | 0.2336 | 4.00 | 7.22 | 274,537.60 | 0.6815 | 1.58 | 0.7138 | 1.73 | 63.98 | 58.89 | 2.92 | 3.73 | 9.06 | 1.75 | 0.2972 | 64.58 | 13.81 | 9.61 | 142.70 | -21.76 | -23.75 | 0.00 |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Jun 2021 | 4.78m | 14.75% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 2021 | 3.52m | 10.85% |
| The Vanguard Group, Inc.as of 30 Jun 2021 | 2.06m | 6.34% |
| Wellington Management Co. LLPas of 30 Jun 2021 | 1.76m | 5.44% |
| Dimensional Fund Advisors LPas of 30 Jun 2021 | 1.54m | 4.76% |
| GAMCO Asset Management, Inc.as of 30 Jun 2021 | 1.52m | 4.68% |
| Goldman Sachs Asset Management LPas of 30 Jun 2021 | 1.11m | 3.42% |
| SSgA Funds Management, Inc.as of 30 Jun 2021 | 1.05m | 3.25% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 2021 | 765.32k | 2.36% |
| Brown Advisory LLCas of 30 Jun 2021 | 730.50k | 2.25% |
